Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company’s lead product Rejuvant—a dietary supplement containing calcium alpha-ketoglutarate with vitamins A or D—has been shown in preclinical studies to extend lifespan in animal models. It also offers a non-invasive DNA methylation test for biological age estimation. No pharmaceutical clinical trial results are reported; the product is marketed as a science-backed nutraceutical for longevity. The company collaborates with the Buck Institute for Research on Aging. Human data are limited to consumer-facing wellness claims.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ponce De Leon Health.